4//SEC Filing
Chen Ivan 4
Accession 0001209191-18-040506
CIK 0001006028other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 7:26 PM ET
Size
7.7 KB
Accession
0001209191-18-040506
Insider Transaction Report
Form 4
Chen Ivan
Director
Transactions
- Award
Common Stock
2018-06-28+150,000→ 150,000 total - Award
Stock Option (Right to Buy)
2018-06-28+200,000→ 200,000 totalExercise: $0.65Exp: 2028-06-28→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.
- [F2]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001743729
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 7:26 PM ET
- Size
- 7.7 KB